Literature DB >> 15504621

Palliative sedation to relieve psycho-existential suffering of terminally ill cancer patients.

Tatsuya Morita1.   

Abstract

To clarify the prevalence and the characteristics of patients who received palliative sedation therapy for psycho-existential suffering, a questionnaire was sent to 105 responsible physicians at all certified palliative care units in Japan. The participants were requested to report the number of patients who received continuous deep sedation for refractory psycho-existential suffering during the past year, and to provide details of the 2 most recent patients. A total of 81 physicians returned questionnaires (response rate, 80%). Twenty-nine physicians (36%) reported clinical experience in continuous deep sedation for psycho-existential suffering. The overall prevalence of continuous deep sedation was calculated as 1.0% (90 cases/8,661 total patient deaths), and a total of 46 patient histories were collected. Performance status just before sedation was 3 or 4 in 96%, and predicted survival was 3 weeks or less in 94%. The suffering requiring sedation was feeling of meaninglessness/worthlessness (61%), burden on others/dependency/inability to take care of oneself (48%), death anxiety/fear/panic (33%), wish to control the time of death by oneself (24%), and isolation/lack of social support (22%). Before sedation, intermittent sedation and specialized psychiatric, psychological, and/or religious care had been performed in 94% and 59%, respectively; 89% of 26 depressed patients had received antidepressant medications. All competent patients (n=37) expressed explicit requests for sedation, and family consent was obtained in all cases where family members were available (n=45). Palliative sedation for psycho-existential suffering was performed in exceptional cases in specialized palliative care units in Japan. The patient condition was generally very poor, and the suffering was refractory to intermittent sedation and specialized psychiatric, psychological, and/or religious care. Sedation was performed on the basis of patient and family consent. These findings suggest that palliative sedation for psycho-existential suffering could be ethically permissible in exceptional cases if the proportionality and autonomy principle is applied. More discussion about the role of palliative sedation therapy for refractory psycho-existential suffering in end-of-life care is urgently necessary.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504621     DOI: 10.1016/j.jpainsymman.2004.02.017

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  18 in total

Review 1.  [Sedation in palliative medicine: Guidelines for the use of sedation in palliative care : European Association for Palliative Care (EAPC)].

Authors:  B Alt-Epping; T Sitte; F Nauck; L Radbruch
Journal:  Schmerz       Date:  2010-08       Impact factor: 1.107

2.  Accessing the ethics of complex health care practices: would a "domains of ethics analysis" approach help?

Authors:  Jeffrey Kirby
Journal:  HEC Forum       Date:  2010-06

3.  Palliative sedation in Latin America: survey on practices and attitudes.

Authors:  Jairo Moyano; Sofia Zambrano; César Ceballos; Carlos Miguel Santacruz; Carlos Guerrero
Journal:  Support Care Cancer       Date:  2007-12-11       Impact factor: 3.603

Review 4.  [A wish to hasten death : what is behind it].

Authors:  S Stiel; F Elsner; M Pestinger; L Radbruch
Journal:  Schmerz       Date:  2010-04       Impact factor: 1.107

5.  Nurses' attitudes and experiences surrounding palliative sedation: components for developing policy for nursing professionals.

Authors:  Bansari Patel; Rita Gorawara-Bhat; Stacie Levine; Joseph W Shega
Journal:  J Palliat Med       Date:  2012-04       Impact factor: 2.947

6.  [Palliative sedation for psycho-existential suffering].

Authors:  Eva Weichselbaumer; Dietmar Weixler
Journal:  Wien Med Wochenschr       Date:  2013-10-25

7.  Patient and/or family controlled palliative sedation with midazolam for intractable symptom control: a case series.

Authors:  Diamanto Aretha; Eleftheria S Panteli; Panagiotis Kiekkas; Menelaos Karanikolas
Journal:  Cases J       Date:  2009-02-11

8.  Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients.

Authors:  Masatoshi Inagaki; Tatsuo Akechi; Toru Okuyama; Yuriko Sugawara; Hiroya Kinoshita; Yasuo Shima; Kimio Terao; Shuichi Mitsunaga; Atsushi Ochiai; Yosuke Uchitomi
Journal:  Support Care Cancer       Date:  2013-02-28       Impact factor: 3.603

9.  [Indications and use of benzodiazepines in a palliative care unit].

Authors:  S Stiel; N Krumm; O Schroers; L Radbruch; F Elsner
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

10.  Palliative sedation in advanced cancer patients hospitalized in a specialized palliative care unit.

Authors:  Santiago Parra Palacio; Clara Elisa Giraldo Hoyos; Camilo Arias Rodríguez; Daniel Mejía Arrieta; John Jairo Vargas Gómez; Alicia Krikorian
Journal:  Support Care Cancer       Date:  2018-03-29       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.